Related Experiment Video
Updated: Jan 26, 2026
08:34
Production of Autologous Platelet-Rich Plasma for Boosting In Vitro Human Fibroblast Expansion
Published on: February 24, 2021
3.0K
Autologous Platelet-Rich Plasma for Nonhealing Ulcers: A Comparative Study
Maria Tsachiridi1,2, George Galyfos1, Alexandros Andreou3
1First Department of Propedeutic Surgery, Hippocration General Hospital, National Kapodistrian University of Athens, Athens, Greece.
Vascular Specialist International
|April 18, 2019
Summary
Platelet-rich plasma (PRP) therapy shows promise for chronic nonhealing ulcers, improving depth and healing rate. Further studies are needed to confirm its effect on ulcer area.
Area of Science:
- Regenerative Medicine
- Wound Healing
- Dermatology
Background:
- Chronic nonhealing ulcers pose a significant clinical challenge.
- Platelet-rich plasma (PRP) is an emerging therapeutic option for wound management.
- Limited data exist on the efficacy of PRP for nonhealing ulcers.
Purpose of the Study:
- To evaluate the therapeutic potential of platelet-rich plasma (PRP) in treating chronic nonhealing ulcers.
- To compare PRP treatment outcomes against conventional methods.
Main Methods:
- A prospective study compared 15 patients treated with autologous PRP weekly (Group A) to 12 patients receiving conventional care (Group B).
- Treatment duration was 5 weeks.
- Ulcer area, depth, and healing rate were assessed.
Main Results:
- PRP group showed a significant reduction in ulcer depth (P=0.0006) and a positive healing rate.
- Conventional group experienced an increase in ulcer area (P=0.016).
- PRP's effect on ulcer area reduction was not statistically significant (P=0.190).
Conclusions:
- Weekly PRP application appears to promote chronic ulcer healing, improving depth and healing rate.
- While not statistically significant, a trend towards reduced ulcer area was observed with PRP.
- Larger studies are required to validate these findings and establish PRP's role in ulcer treatment.
Related Concept Videos
01:28Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
562
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
562
01:28Peptic Ulcer Disease II: Pathophysiology
2.0K
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
2.0K
01:30Peptic Ulcer Disease I: Introduction
770
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
770
01:26Peptic Ulcer Disease IV: Management
465
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
465
02:26Comparing Copy Number Variations and SNPs
18.7K
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
18.7K
01:18Structure and Function of Platelets
3.3K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
3.3K